Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers

卵巢癌 输卵管癌 神秘的 输卵管 医学 前瞻性队列研究 BRCA突变 妇科 癌症 乳腺癌 产科 队列 介绍 基因检测 肿瘤科 内科学 病理 家庭医学 替代医学
作者
Susan M. Domchek,Tara M. Friebel,Judy E. Garber,Claudine Isaacs,Ellen Matloff,Rosalind A. Eeles,D. Gareth Evans,Wendy S. Rubinstein,Christian F. Singer,Stephen C. Rubin,Henry T. Lynch,Mary B. Daly,Jeffrey N. Weitzel,Patricia A. Ganz,Gabriella Pichert,Olufunmilayo I. Olopade,Gail E. Tomlinson,Nadine Tung,Joanne L. Blum,Fergus J. Couch
出处
期刊:Breast Cancer Research and Treatment [Springer Science+Business Media]
卷期号:124 (1): 195-203 被引量:69
标识
DOI:10.1007/s10549-010-0799-x
摘要

Risk-reducing salpingo-oophorectomy (RRSO) is widely used for cancer risk reduction in BRCA1 or BRCA2 (BRCA1/2) mutation carriers. Occult ovarian/fallopian tube cancers (OOC) detected at the time of RRSO have been reported in several studies with wide variability in reported prevalence. We estimated the prevalence of OOC in a prospective cohort of 647 BRCA1/2 mutation carriers from 18 centers (PROSE consortium) who underwent RRSO between 2001 and 2008. OOC was detected in 16 of 647 women (2.5%). The mean age at RRSO was 51.7 in those with OOC versus 46.6 in those without OOC (P = 0.017). Twelve of the 16 OOCs (75%) were diagnosed in women with BRCA1 mutations. Thirty-eight percent of women with OOC had stage 1 cancer versus none of the women in the PROSE database diagnosed with ovarian cancer outside of screening. Among 385 women (60%) in whom pathology reports were available for central review, 246 (64%) RRSOs were performed at participating PROSE centers while 139 (36%) were performed at local sites. Ovarian and fallopian tube tissues removed at major genetics referral centers were significantly more likely to have been examined in toto compared to specimens obtained at non-referral centers (75% vs. 30%, P < 0.001). Our results confirm that OOC may be found at the time of RRSO in BRCA1/2 mutation carriers and suggest that OOC are of a more favorable stage than cancers found outside RRSO. An unacceptably high proportion of pathologic examinations did not adequately examine ovaries and fallopian tubes obtained at RRSO.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
molihuakai的应助被322采纳,获得10
1秒前
罗战菊完成签到 ,获得积分10
2秒前
2秒前
wxqz完成签到,获得积分20
2秒前
大气幻柏发布了新的文献求助10
2秒前
3秒前
CipherSage的应助被土豆采纳,获得10
4秒前
打打的应助被啦啦啦采纳,获得10
4秒前
djuanyx完成签到,获得积分10
4秒前
4秒前
葡萄完成签到,获得积分10
4秒前
haung完成签到,获得积分10
4秒前
510完成签到,获得积分10
5秒前
王知颖发布了新的文献求助10
6秒前
wxqz发布了新的文献求助10
6秒前
6秒前
6秒前
Lucas的应助被胖头鱼采纳,获得50
7秒前
8秒前
10秒前
皮卡丘发布了新的文献求助10
10秒前
艾格的应助被风吹麦浪采纳,获得10
11秒前
322完成签到,获得积分10
11秒前
11秒前
霸气雁露完成签到,获得积分10
11秒前
11秒前
赛妮完成签到,获得积分10
12秒前
12秒前
11完成签到,获得积分10
13秒前
完美世界的应助被向晚采纳,获得10
13秒前
无极微光的应助被soon采纳,获得30
15秒前
科研通AI6.3的应助被HUQ采纳,获得10
15秒前
15秒前
77完成签到,获得积分10
15秒前
RobiN发布了新的文献求助10
16秒前
啵子发布了新的文献求助30
16秒前
17秒前
17秒前
Gabriel1116完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188118
求助须知:如何正确求助?哪些是违规求助? 9575977
关于积分的说明 21844428
捐赠科研通 7785918
什么是DOI,文献DOI怎么找? 3435205
关于科研通互助平台的介绍 2559558
邀请新用户注册赠送积分活动 2482065